ID: ALA2017025

Max Phase: Preclinical

Molecular Formula: C17H24N6O6S

Molecular Weight: 440.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4C[C@H]5CCC4C5)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C17H24N6O6S/c18-30(26,27)28-5-11-13(24)14(25)17(29-11)23-7-21-12-15(19-6-20-16(12)23)22-10-4-8-1-2-9(10)3-8/h6-11,13-14,17,24-25H,1-5H2,(H2,18,26,27)(H,19,20,22)/t8-,9?,10+,11+,13+,14+,17+/m0/s1

Standard InChI Key:  MZJLOMLHSSUWBH-XXTQSAJPSA-N

Associated Targets(Human)

SUMO-activating enzyme 861 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ubiquitin-like modifier-activating enzyme 5 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 440.48Molecular Weight (Monoisotopic): 440.1478AlogP: -0.73#Rotatable Bonds: 6
Polar Surface Area: 174.71Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: 3.73CX LogP: -0.77CX LogD: -0.77
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: 0.47

References

1. Lukkarila JL, da Silva SR, Ali M, Shahani VM, Xu GW, Berman J, Roughton A, Dhe-Paganon S, Schimmer AD, Gunning PT..  (2011)  Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity.,  (8): [PMID:24900352] [10.1021/ml2000615]

Source